ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HERBERT LEE MD

Cardiovascular Disease

323

$5,451

57
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 28%

$17
Average prescription price

Avg: $67

GARY MARSH M.D.

Cardiovascular Disease

1,657

$33.1K

212
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$20
Average prescription price

Avg: $67

RICHARD HART M.D.

Cardiovascular Disease

1,734

$35.9K

283
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 28%

$21
Average prescription price

Avg: $67

ARMEN AGHABEGIAN P.A.

Cardiovascular Disease

253

$5,290

96
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$21
Average prescription price

Avg: $67

CHULANI KAPPAGODA MBBS, PHD

Cardiovascular Disease

920

$20.4K

71
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$22
Average prescription price

Avg: $67

MICHAEL DAM MD

Cardiovascular Disease

6,479

$150K

1051
978 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$23
Average prescription price

Avg: $67

NHON NGUYEN MD

Cardiovascular Disease

1,735

$40.6K

182
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 28%

$23
Average prescription price

Avg: $67

LAURENCE FAVROT MD

Cardiovascular Disease

1,627

$38.3K

311
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

3%
prescriptions for brand name drugs

Avg: 28%

$24
Average prescription price

Avg: $67

JOSEPH GHAZAL M.D.

Cardiovascular Disease

472

$11.2K

65
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$24
Average prescription price

Avg: $67

JESSICA LI M.D.

Cardiovascular Disease

1,511

$37.4K

162
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$25
Average prescription price

Avg: $67

RAMA THUMATI MD

Cardiovascular Disease

17,733

$453K

1253
1161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$26
Average prescription price

Avg: $67

KENNETH WEN MD

Cardiovascular Disease

1,916

$50.2K

208
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$26
Average prescription price

Avg: $67

CESAR ARANGURI M.D.

Cardiovascular Disease

2,361

$62.2K

321
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$26
Average prescription price

Avg: $67

HOWARD STANILOFF M.D.

Cardiovascular Disease

831

$22.1K

71
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$27
Average prescription price

Avg: $67

BYRON SONG MD

Cardiovascular Disease

4,104

$112K

173
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$27
Average prescription price

Avg: $67

PHILLIP HARDING M.D.

Cardiovascular Disease

776

$21.4K

74
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$28
Average prescription price

Avg: $67

PADMINI TUMMALA MD

Cardiovascular Disease

4,665

$132K

580
525 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 28%

$28
Average prescription price

Avg: $67

DAVID PLOSS M.D.

Cardiovascular Disease

5,170

$147K

529
466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$28
Average prescription price

Avg: $67

HUMAYUN QURESHI M.D.

Cardiovascular Disease

2,294

$65.1K

375
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$28
Average prescription price

Avg: $67

RICHARD SPELLBERG M.D.

Cardiovascular Disease

925

$26.4K

78
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$29
Average prescription price

Avg: $67

RAMESH DHARAWAT M.D.

Cardiovascular Disease

4,058

$116K

348
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$29
Average prescription price

Avg: $67

MILAN RAWAL M.D.

Cardiovascular Disease

1,891

$54.4K

175
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$29
Average prescription price

Avg: $67

JOHN SCHATZ M.D.

Cardiovascular Disease

1,155

$33.9K

99
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$29
Average prescription price

Avg: $67

HASHEM FATEMI

Cardiovascular Disease

904

$26.7K

95
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$29
Average prescription price

Avg: $67

ANANT VYAS MD

Cardiovascular Disease

1,630

$48.2K

134
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 28%

$30
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank